BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• Deals

  Westaim Corporation’s NUCRYST Pharmaceuticals Corp. Unit Files For U.S. IPO

  December 2, 2005

   · 

  1 min read
• Genetown

  Point Therapeutics Announces Exercise And Closing Of Underwriters’ Over-Allotment Option; Aggregate Of $25.8 Million Raised

  December 2, 2005

   · 

  1 min read
• Biotech Bay

  ALZA Corporation Modifies U.S. Clinical Development Program For OROS Hydromorphone (AP-77)

  December 2, 2005

   · 

  2 min read
• Policy

  Inspire Pharmaceuticals Announces Receipt Of FDA Approvable Letter For Diquafosol; FDA Says Studies Insufficient

  December 2, 2005

   · 

  1 min read
• Biotech Beach

  Spectrum Pharmaceuticals, Inc. To Provide Company Update At The First Albany Annual Growth Conference

  December 2, 2005

   · 

  2 min read
• Pharm Country

  Callisto Pharmaceuticals Announces Poster Presentation on Atiprimod At Major Scientific Meeting In December

  December 2, 2005

   · 

  1 min read
• Policy

  TEVA Pharmaceuticals USA Announces FTC Will Not File Objections To Effexor(R) XR Settlement

  December 2, 2005

   · 

  1 min read
• Business

  Sanofi-Aventis (France) To Inject EUR 51 Million For Frankfurt Expansion

  December 2, 2005

   · 

  1 min read
• Drug Development

  Ligand Pharmaceuticals Inc. Collaborator Drug Shows Encouraging Results In Thrombocytopenia; GlaxoSmithKline Releases Phase II Data; Ligand Drug For Thrombocytopenia Targeted For IND Filing 1H'06

  December 2, 2005

   · 

  1 min read
• FDA

  St. Jude Medical Announces FDA Approval And Market Launch Of New Cardiac Ablation Generator And Therapy(TM) Catheters

  December 2, 2005

   · 

  1 min read